HAVCR2 and neoplasm: PD-1, PD-L1, TIM-3, and B7 molecules are expressed by subsets of TAMs and DCs, and consist therapeutic targets facilitating the inhibition of the function of these cells and the subsequent elimination of the tumor (Figure 3).